Elevation Wealth Partners’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$36.8K Buy
356
+105
+42% +$9.37K 0.01% 386
2026
Q1
$18K Hold
251
0.01% 402
2025
Q4
$19.9K Buy
251
+51
+26% +$4.02K 0.01% 369
2025
Q3
$15.1K Buy
200
+130
+186% +$8.91K 0.01% 351
2025
Q2
$4.83K Hold
70
﹤0.01% 405
2025
Q1
$4.74K Sell
70
-400
-85% -$23.9K ﹤0.01% 407
2024
Q4
$21.1K Buy
470
+70
+18% +$3.93K 0.01% 306
2024
Q3
$25.2K Hold
400
0.01% 284
2024
Q2
$23.6K Sell
400
-100
-20% -$6.25K 0.01% 282
2024
Q1
$39.9K Hold
500
0.02% 236
2023
Q4
$34.9K Buy
500
+400
+400% +$28.5K 0.02% 235
2023
Q3
$6.98K Hold
100
0.01% 260
2023
Q2
$6.91K Hold
100
0.01% 266
2023
Q1
$7.43K Buy
+100
New +$8.39K 0.01% 273

Other funds holding CVS

Elevation Wealth Partners's CVS Position: Q2 2026 in Review

Elevation Wealth Partners increased its CVS Health (CVS) stake by 42% in Q2 2026, buying an estimated $9.37K and bringing the position to 356 shares worth $36.8K. The position accounts for 0.01% of the portfolio, ranked #386.

Elevation Wealth Partners first reported a position in CVS in Q1 2023 and has held it in 14 quarters since. The position peaked at $39.9K in Q1 2024. 886 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Elevation Wealth Partners held 356 shares of CVS Health worth $36.8K as of Q2 2026.
  • Elevation Wealth Partners bought 105 CVS Health shares in Q2 2026, an estimated $9.37K.
  • CVS Health made up 0.01% of Elevation Wealth Partners's portfolio in Q2 2026, its #386 holding.
  • Elevation Wealth Partners first reported a position in CVS Health in Q1 2023 and has held it in 14 quarters since.
  • Elevation Wealth Partners's CVS Health position peaked at $39.9K in Q1 2024.
  • 886 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Elevation Wealth Partners's 13F filing for Q2 2026, filed 8 Jul 2026.